AstraZeneca PLC (BVMF:A1ZN34)

AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of BRL 1.46 trillion. The enterprise value is 1.59 trillion.

Market Cap	1.46T
Enterprise Value	1.59T

Important Dates

The last earnings date was Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	Aug 7, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	80.57%
Float	1.54B

Valuation Ratios

The trailing PE ratio is 29.13 and the forward PE ratio is 17.68.

PE Ratio	29.13
Forward PE	17.68
PS Ratio	4.71
PB Ratio	5.96
P/TBV Ratio	n/a
P/FCF Ratio	21.63
P/OCF Ratio	18.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.74, with an EV/FCF ratio of 23.52.

EV / Earnings	31.68
EV / Sales	5.26
EV / EBITDA	14.74
EV / EBIT	19.23
EV / FCF	23.52

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.71.

Current Ratio	0.88
Quick Ratio	0.69
Debt / Equity	0.71
Debt / EBITDA	1.57
Debt / FCF	2.58
Interest Coverage	12.24

Financial Efficiency

Return on equity (ROE) is 21.67% and return on invested capital (ROIC) is 13.17%.

Return on Equity (ROE)	21.67%
Return on Assets (ROA)	9.07%
Return on Invested Capital (ROIC)	13.17%
Return on Capital Employed (ROCE)	19.79%
Revenue Per Employee	3.29M
Profits Per Employee	531,188
Employee Count	94,300
Asset Turnover	0.53
Inventory Turnover	1.59

Taxes

In the past 12 months, AstraZeneca has paid 10.85 billion in taxes.

Income Tax	10.85B
Effective Tax Rate	17.79%

Stock Price Statistics

The stock price has increased by +25.24% in the last 52 weeks. The beta is 0.17, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+25.24%
50-Day Moving Average	73.03
200-Day Moving Average	69.43
Relative Strength Index (RSI)	58.42
Average Volume (20 Days)	1,710

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of BRL 309.78 billion and earned 50.09 billion in profits. Earnings per share was 32.08.

Revenue	309.78B
Gross Profit	257.92B
Operating Income	84.81B
Pretax Income	60.96B
Net Income	50.09B
EBITDA	108.84B
EBIT	84.81B
Earnings Per Share (EPS)	32.08

Balance Sheet

The company has 43.61 billion in cash and 174.06 billion in debt, giving a net cash position of -130.46 billion.

Cash & Cash Equivalents	43.61B
Total Debt	174.06B
Net Cash	-130.46B
Net Cash Per Share	n/a
Equity (Book Value)	245.00B
Book Value Per Share	157.68
Working Capital	-21.93B

Cash Flow

In the last 12 months, operating cash flow was 80.69 billion and capital expenditures -13.23 billion, giving a free cash flow of 67.46 billion.

Operating Cash Flow	80.69B
Capital Expenditures	-13.23B
Free Cash Flow	67.46B
FCF Per Share	n/a

Margins

Gross margin is 83.26%, with operating and profit margins of 27.38% and 16.17%.

Gross Margin	83.26%
Operating Margin	27.38%
Pretax Margin	19.68%
Profit Margin	16.17%
EBITDA Margin	35.13%
EBIT Margin	27.38%
FCF Margin	21.78%

Dividends & Yields

This stock pays an annual dividend of 1.39, which amounts to a dividend yield of 1.78%.

Dividend Per Share	1.39
Dividend Yield	1.78%
Dividend Growth (YoY)	13.77%
Years of Dividend Growth	3
Payout Ratio	52.89%
Buyback Yield	0.08%
Shareholder Yield	1.86%
Earnings Yield	3.43%
FCF Yield	4.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 2.98 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.98
Piotroski F-Score	7